Given the regulatory role of hepatic hepcidin and iron metabolism in lipid homeostasis and MASLD progression [33], measuring HAMP1 expression in blood or liver tissue may provide predictive insights into treatment responsiveness. Here, HAMP is linked to metabolic dysfunction-associated steatotic liver disease.